Abstract
Rapid development of molecularly targeted drugs requires a "companion diagnostic" that could delay drug development and limit availability of active drugs for relevant patients.
Original language | English |
---|---|
Pages (from-to) | 4422-4424 |
Number of pages | 3 |
Journal | Clinical Cancer Research |
Volume | 20 |
Issue number | 17 |
DOIs | |
State | Published - 2014 |
Externally published | Yes |